Subject: Fwd: Gilead & USCDC Bios
From: nino mamaladze <[email-masked]>
To: [email-masked]
Date: Mon, 20 Apr 2015 06:13:19 +0000

-----Original Message-----
From: ვალერი კვარაცხელია <[email-masked]>
To: [email-masked]
Date: Mon, 20 Apr 2015 10:10:33 +0400
Subject: Fwd: Gilead & USCDC Bios

საქართველოს შრომის
ჯანმრთელობისა დაცვის
სოციალური დაცვის
მინისტრის მოადგილე
ვალერი კვარაცხელია

-------- Исходное сообщение --------
От: Graeme Robertson <[email-masked]> 
Дата:20.04.2015  0:43  (GMT+04:00) 
Кому: David Chitaia <[email-masked]> 
Копия: David Sergeenko <[email-masked]>,"valeri
([email-masked])" <[email-masked]>,Enrico
Magnanelli <[email-masked]>,Sonia Choi
<[email-masked]> 
Тема: Gilead & USCDC Bios 

Dear David,
 
Please find attached the Bios for the Gilead delegation and USCDC
attending the signing ceremony.
 
Best wishes
 
Graeme
 
Graeme Robertson
Director
Access Operations & Emerging Markets 

-------------------------------------------------------------------------
-------------------------------------------------------------------------
Gilead Sciences Europe Ltd • Registered as a limited company in England
and Wales • Registered number 05510315
Registered office: South Building • 2 Roundwood Avenue • Stockley
Park • Uxbridge • UB11 1AZ • England
Telephone: +44(0)208 587 2228 • Mobile: +44(0)7789 268 043 • Fax:
+44(0)208 744 6773

DISCLAIMER If you have received this message in error, please contact the
sender immediately by return e-mail and notify the sender and then delete
this message (including any attachments) from your system. This
communication and any attachments contain information which is
confidential and may also be legally privileged. It is for the exclusive
use of the intended recipient(s). If you are not the intended
recipient(s) please note that any form of disclosure, distribution,
copying or use of this communication or the information in it or in any
attachments is strictly prohibited and may be unlawful. E-mail
communications cannot be guaranteed to be secure or error free, as
information could be intercepted, corrupted, amended, lost, destroyed,
arrive late or incomplete, or contain viruses. Gilead does not accept
liability for any such matters or their consequences. Anyone who
communicates with Gilead by e-mail is taken to accept the risks in doing
so. Gilead has taken every reasonable precaution to ensure that any
attachment to this e-mail has been swept for viruses. However, Gilead
cannot accept liability for any damage sustained as a result of viruses
and would advise that you carry out your own virus checks before opening
any attachment. Gilead Sciences Europe Ltd ; Registered as a limited
company in England and Wales ; Registered number 5510315 Registered
office: South Building ; 2 Roundwood Avenue ; Stockley Park ; Uxbridge ;
UB11 1AF ; England